Corbenic Partners LLC Merck & Co., Inc. Transaction History

Corbenic Partners LLC

$380 Million
Q2 2022

A detailed history of Corbenic Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corbenic Partners LLC holds 269 shares of MRK stock, worth $30,547. This represents 0.01% of its overall portfolio holdings.

Number of Shares

269

Previous 658 59.12%

Holding current value

$30,547

Previous $54,000 53.7%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $32,477 - $36,814	-389 Reduced 59.12%	269 $25,000
Q1 2022 Apr 14, 2022	SELL	$73.51 - $82.4 $6.14 Million - $6.88 Million	-83,537 Reduced 99.22%	658 $54,000
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $394,937 - $494,710	5,464 Added 6.94%	84,195 $6.51 Million
Q3 2021 Oct 13, 2021	BUY	$71.68 - $78.83 $391,659 - $430,727	5,464 Added 7.46%	78,731 $5.96 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $515,864 - $570,598	7,337 Added 11.13%	73,267 $5.75 Million
Q1 2021 Apr 14, 2021	BUY	$68.86 - $81.11 $721,859 - $850,276	10,483 Added 18.91%	65,930 $5.12 Million
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $48,947 - $54,321	682 Added 1.25%	55,447 $4.57 Million
Q3 2020 Oct 09, 2020	BUY	$73.18 - $82.95 $20,929 - $23,723	286 Added 0.52%	54,765 $4.58 Million
Q2 2020 Jul 17, 2020	SELL	$70.42 - $80.13 $27,815 - $31,651	-395 Reduced 0.72%	54,479 $4.25 Million
Q1 2020 Apr 16, 2020	BUY	$63.36 - $87.82 $519,615 - $720,211	8,201 Added 17.57%	54,874 $4.25 Million
Q4 2019 Jan 14, 2020	BUY	$77.58 - $87.54 $881,851 - $995,067	11,367 Added 32.2%	46,673 $4.27 Million
Q4 2017 Jan 25, 2018	BUY	$51.62 - $61.64 $31,384 - $37,477	608 Added 1.75%	35,306 $2 Million
Q3 2017 Oct 26, 2017	SELL	$58.67 - $63.13 $14,902 - $16,035	-254 Reduced 0.73%	34,698 $2.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,952	34,952 $2.24 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corbenic Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corbenic Partners LLC with notifications on news.

Account

Corbenic Partners LLC Merck & Co., Inc. Transaction History